Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
833.6 DKK | -0.86% | +3.30% | +7.98% |
Jun. 06 | Transcript : Coloplast A/S - Analyst/Investor Day | |
May. 15 | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |
Sales 2024 * | 27.04B 3.9B | Sales 2025 * | 29.37B 4.23B | Capitalization | 189B 27.25B |
---|---|---|---|---|---|
Net income 2024 * | 5.24B 756M | Net income 2025 * | 6.11B 881M | EV / Sales 2024 * | 7.71 x |
Net Debt 2024 * | 19.4B 2.8B | Net Debt 2025 * | 18.07B 2.61B | EV / Sales 2025 * | 7.05 x |
P/E ratio 2024 * |
36.2
x | P/E ratio 2025 * |
31
x | Employees | 15,930 |
Yield 2024 * |
2.39% | Yield 2025 * |
2.62% | Free-Float | 58.44% |
Latest transcript on Coloplast A/S
1 day | -0.74% | ||
1 week | +3.37% | ||
Current month | +1.14% | ||
1 month | -1.16% | ||
3 months | -13.57% | ||
6 months | +11.46% | ||
Current year | +8.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 07-12-31 | |
Director of Finance/CFO | 52 | 05-12-31 | |
Chairman | 65 | 87-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 68-09-30 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 17-11-30 |
Chairman | 65 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.81% | 218 M€ | +18.22% | ||
1.11% | 252 M€ | +7.82% | ||
0.96% | 51 M€ | +9.03% | ||
0.85% | 3 M€ | +9.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 833.6 | -0.86% | 239 590 |
24-06-07 | 840.8 | +1.35% | 280,671 |
24-06-06 | 829.6 | +1.39% | 328,513 |
24-06-04 | 818.2 | +1.39% | 179,324 |
24-06-03 | 807 | -2.16% | 352,143 |
Delayed Quote Nasdaq Copenhagen, June 10, 2024 at 03:32 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.06% | 27.39B | |
-41.00% | 2.63B | |
+26.30% | 2.48B | |
-23.19% | 2.31B | |
+5.99% | 2.21B | |
-14.16% | 1.81B | |
+33.51% | 1.34B | |
+25.38% | 1.32B | |
+1.64% | 1.25B | |
+32.62% | 1.04B |
- Stock Market
- Equities
- COLO B Stock